RETRACTED: A long-term effect of epalrestat on motor conduction velocity of diabetic patients: ARI-Diabetes Complications Trial (ADCT)

Autor:	Yukio Shigeta, Yoshitomo Oka, Kempei Matsuoka, Nigishi Hotta, Takayoshi Toyota, Ryuzo Kawamori, Motoaki Shichiri, Yasuo Akanuma, Nobuo Sakamoto
Rok vydání:	2007
Předmět:	Male Gerontology medicine.medical_specialty Rhodanine Endocrinology Diabetes and Metabolism Neural Conduction Gastroenterology Nerve conduction velocity Body Mass Index law.invention chemistry.chemical_compound Endocrinology Diabetic Neuropathies Randomized controlled trial Aldehyde Reductase law Internal medicine Diabetes mellitus Diabetes Mellitus Internal Medicine medicine Humans Prospective Studies Age of Onset Enzyme Inhibitors Prospective cohort study Epalrestat Aged Glycated Hemoglobin Motor Neurons business.industry General Medicine Middle Aged medicine.disease Aldose reductase inhibitor Diabetes Mellitus Type 2 chemistry Thiazolidines Female Age of onset business medicine.drug Retinopathy
Zdroj:	Diabetes Research and Clinical Practice. 77:S263-S268
ISSN:	0168-8227
DOI:	10.1016/j.diabres.2007.01.069
Popis:	In order to study a long-term effect along with adverse action of epalrestat, an aldose reductase inhibitor, a randomized, prospective study was conducted over the period of 3 years at 112 facilities. Six hundred and three diabetic patients with median motor conduction velocity (MCV)>40 m/s, HbA1c
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcbf30d316b03be16827e9e479190e5f https://doi.org/10.1016/j.diabres.2007.01.069 Zobrazit plný text záznamu Full Text from ScienceDirect